Mimedx Group, Inc.
MDXG- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001376339
No open-market purchases or sales by Mimedx Group, Inc. insiders were filed in the last 90 days; 227 institutions reported holding it in 13F filings for Q2 2026, worth $449.2M in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, −9 vs. previous quarter
- 227
- 13F valueReported value at the end of Q2 2026
- $449.2M
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding MDXG, Q2 2026
No superinvestor reported holding MDXG at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Mimedx Group, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 10, 2025 (view filing) | Nov 6 | 4 days | Maersk-Moller KimberlyChief Commercial Officer | SSale | −58.3K | $7.42 | −$432.6K | −19.7%237.0K after | |
| May 5, 2025 (view filing) | May 2 | 3 days | Capper Joseph HChief Executive Officer | PPurchase | +200.0K | $6.34 | +$1.27M | +60.7%529.5K after | |
| Mar 20, 2025 (view filing) | Mar 17 | 3 daysLate | Maersk-Moller KimberlyChief Commercial Officer | SSale | −1.76K | $8.04 | −$14.1K | −0.6%309.1K after | |
| Mar 14, 2025 (view filing) | Mar 13 | 1 day | Hulse William Frank IVGeneral Counsel and CAO | SSale | −54.6K | $7.89 | −$430.8K | −11.0%440.2K after | 2 lots |
| Mar 14, 2025 (view filing) | Mar 13 | 1 day | Maersk-Moller KimberlyChief Commercial Officer | SSale | −4.11K | $7.89 | −$32.4K | −1.3%310.8K after | |
| Mar 12, 2025 (view filing) | Mar 10 | 2 days | Hulse William Frank IVGeneral Counsel and CAO | SSale | −81.4K | $7.80 | −$635.3K | −14.1%494.8K after | |
| Mar 5, 2025 (view filing) | Feb 28 | 5 daysLate | Maersk-Moller KimberlyChief Commercial Officer | SSale | −2.11K | $8.41 | −$17.8K | −0.8%265.3K after | |
| Feb 18, 2025 (view filing) | Feb 13 | 5 days | Whitlow Ricci SChief Operating Officer | SSale | −61.4K | $8.28 | −$508.6K | −13.2%403.0K after | |
| Mar 15, 2024 (view filing) | Mar 13 | 2 days | Hulse William Frank IVGeneral Counsel and CAO | SSale | −20.4K | $7.95 | −$162.0K | −4.1%480.0K after | |
| Feb 21, 2024 (view filing) | Feb 16-20 | 5 days | Whitlow Ricci SChief Operating Officer | SSale | −30.8K | $8.04 | −$247.3K | −7.1%401.1K after | 2 lots |
Top 10 13F holders, Q2 2026
The largest institutional positions in Mimedx Group, Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Essex Woodlands Management, Inc. | 28,195,249 | $108.6M | 42.70% | 00.0% | Unchanged |
| BlackRock, Inc. | 12,154,466 | $46.8M | 0.00% | +243,166+2.0% | Added |
| Nantahala Capital Management, LLC | 9,535,104 | $36.7M | 1.11% | +6,137,805+180.7% | Added |
| Trigran Investments, Inc. | 7,173,770 | $27.6M | 5.07% | −1,3390.0% | Reduced |
| State Street Corp | 5,578,920 | $21.5M | 0.00% | +522,119+10.3% | Added |
| Vanguard Capital Management LLC | 5,187,053 | $20.0M | 0.00% | +21,047+0.4% | Added |
| Paradigm Capital Management Inc | 4,073,100 | $15.7M | 0.43% | +662,800+19.4% | Added |
| Geode Capital Management, LLC | 3,143,488 | $12.1M | 0.00% | +262,329+9.1% | Added |
| Goldman Sachs Group Inc | 2,665,562 | $10.3M | 0.00% | +1,480,001+124.8% | Added |
| AQR Capital Management LLC | 2,467,005 | $9.50M | 0.00% | +1,554,277+170.3% | Added |